Page 3 - Astrazeneca

AstraZeneca to invest Rs 250 crore in expanding its GITC in Chennai

This will be the company's largest GCC in the world. This is a monumental addition by the company, joining other global giants like Hitachi Energy in establishing their biggest GCCs in Chennai

AstraZeneca's Imfinzi fails in late-stage trial to treat lung cancer cases

Imfinzi is a human monoclonal antibody, which works to block a tumour's ability to evade and dampen the immune system, while also boosting the body's anti-cancer immune response

AstraZeneca chemotherapy gets US nod for certain type of endometrial cancer

Endometrial cancer ranks as the fourth most prevalent cancer among women in the US. In 2022, it affected more than 66,000 patients

Stocks to watch on May 28: LIC, Natco Pharma, AstraZeneca India, Nalco

Stocks to watch on May 28: LIC reported a 15.6 per cent year on year (YoY) increase in standalone net premium income, reaching Rs 1.52 lakh crore in Q4FY24 compared to Rs 1.32 lakh crore

AstraZeneca Q4 results: Net profit jumps 128%, revenue rises 34.59%

Strategic collaborations played a crucial role in AstraZeneca's achievements, particularly in enhancing diagnostic capabilities and treatment outcomes

Q4 results today: LIC, NMDC, AstraZeneca among 303 firms to post earnings

Q4 FY24 company results: Elgi Equipments, Natco Pharma, Nalco, Goodyear India, and IFB Ind will be releasing their fourth quarter report on May 27

State regulators asked to withdraw marketing of cancer drug Olaparib

Manufacturer AstraZeneca Pharma India says its study shows drug may have detrimental effect

AstraZeneca aims to grow its total revenue by 75% to $80 bn by 2030

The Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030

AstraZeneca to establish $1.5 billion cancer drug plant in Singapore

The facility, which will be the drugmaker's first end-to-end ADC production site, will be supported by the Singapore Economic Development Board

AstraZeneca's anti-Covid drug cuts disease risk in vulnerable patients

The long-acting antibody therapy called sipavibart showed a "statistically significant reduction" in symptomatic Covid-19 cases among immunocompromised patients

After Covishield, new study 'finds' side effects in Covaxin recipients

In observational study on Bharat Biotech's Covaxin recipients, about one-third of participants reported adverse events

Rare blood clots from J&J and AstraZeneca Covid shots linked to genetics

Out of more than 18 million people who received the single-dose J&J vaccine, 60 cases of the clotting disorder were reported and nine people died, according to the Yale School of Medicine

Pfizer, AstraZeneca announce new investments of nearly $1 bn in France

Their investment pledges came as President Emmanuel Macron prepared to kick off on Monday the annual 'Choose France' event aimed at wooing big overseas businesses and investors

AstraZeneca to withdraw Covid-19 vaccine Vaxzevria globally on weak demand

AstraZeneca will start the withdrawal of marketing authorisation for the vaccine in Europe

Not producing, distributing Covishield since December 2021: Serum Institute

AstraZeneca Covid vaccine row: As of April 30, 2024, over 1.7 billion doses of the Covishield vaccine has been administered in India

Serum Institute responds for first time on Covishield amid safety row

Serum Institute of India says it stopped manufacturing Covishield since December 2021

AstraZeneca withdraws Covid-19 vaccine

AstraZeneca that manufactured Covid-19 vaccine 'Covishield', has announced its global withdrawal, days after admitting that the vaccine has rare side effects. It has cited 'commercial reasons' for th

Highlights of the day: Joe Biden says anti-Semitism has 'no place' on any US campus

Latest news updates: Catch all the news updates from around the world here

Why Covishield vaccine case doesn't qualify for medical negligence in India

Given the oversight of different regulatory bodies and that Covishield is produced locally by Serum Institute of India, Indian users may not be able to join the British lawsuit

PM Modi missing from Covid certificates after Covishield row: Here's why

Ministry of Health and Family Welfare informed that PM Modi's photo was removed from Covid certificates due to the Model Code of Conduct (MCC) in effect for the ongoing Lok Sabha polls